The potential anticancer activity of extracts derived from the roots of Scutellaria baicalensis on human oral squamous cell carcinoma cells

被引:21
作者
Sato, Daisuke [1 ]
Kondo, Seiji [1 ]
Yazawa, Kazunaga [2 ]
Mukudai, Yoshiki [1 ]
Li, Chunnan [1 ]
Kamatani, Takaaki [1 ]
Katsuta, Hideyuki [1 ]
Yoshihama, Yasuto [1 ]
Shirota, Tatsuo [1 ]
Shintani, Satoru [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Ota Ku, 2-1-1 Kitasenzoku, Tokyo 1458515, Japan
[2] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Lab Nutraceut & Funct Foods Sci, Minato Ku, Tokyo 1088477, Japan
基金
日本学术振兴会;
关键词
herbal product; anticancer therapeutic agents; human oral squamous cell carcinoma; angiogenesis;
D O I
10.3892/mco.2012.14
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Various herb products derived from plants have potent biological effects including anticancer activity. In the present study, the antitumor activity of a herbal product derived from the Scutellaria baicalensis (S. baicalensis) was examined, using in vitro assays in a human oral squamous cell carcinoma (OSCC) cell line. Results showed that S. baicalensis root extract at the concentration of 100 mu g/ml inhibited monolayer- and anchorage-independent growth in human OSCC cell lines, while not affecting the adhering abilities of cells. This suggested that it did not alter the expression of any of the adhesion receptors that mediate cell-extracellular matrix (ECM) interactions. The S. baicalensis root extract demonstrated potent cytostatic and apoptotic effects due to the downregulation of the cyclin-dependent kinase 4 expression and its partner cyclin D1, resulting in G1 arrest and poly (ADP-ribose) polymerase (PARP) cleavage. Additionally, the S. baicalensis root extract was found to have blocked vascular endothelial growth factor (VEGF)-induced migration and tube formation in human endothelial cells. Taken together, these results demonstrate that as a herbal product, the S. baicalensis root extract is a potential inhibitor of tumori- and angiogenesis and may be valuable in the development of pharmaceutical medications for the treatment of oral squamous cell carcinoma.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 27 条
[1]   Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines [J].
Adams, LS ;
Seeram, NP ;
Hardy, ML ;
Carpenter, C ;
Heber, D .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2006, 3 (01) :117-124
[2]   Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma [J].
Bonham, M ;
Posakony, J ;
Coleman, I ;
Montgomery, B ;
Simon, J ;
Nelson, PS .
CLINICAL CANCER RESEARCH, 2005, 11 (10) :3905-3914
[3]  
Emami SA, 2011, EVID-BASED COMPL ALT, V2011
[4]   Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis [J].
Fas, Stefanie C. ;
Baumann, Sven ;
Zhu, Jia Yun ;
Giaisi, Marco ;
Treiber, Monika K. ;
Mahlknecht, Ulrich ;
Krammer, Peter H. ;
Li-Weber, Min .
BLOOD, 2006, 108 (12) :3700-3706
[5]   An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study [J].
Hsu, Chung-Hua ;
Hwang, Kung-Chang ;
Chao, Chung-Liang ;
Chang, Steve G. N. ;
Ho, Mei-Shang ;
Lin, Jaung-Geng ;
Chang, Hen-Hong ;
Kao, Shung-Te ;
Chen, Yi-Ming ;
Chou, Pesus .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2008, 5 (03) :355-362
[6]   Anti-hepatitis B virus effects of wogonin isolated from Scutellaria baicalensis [J].
Huang, RL ;
Chen, CC ;
Huang, HL ;
Chang, CG ;
Chen, CF ;
Chang, CM ;
Hsieh, MT .
PLANTA MEDICA, 2000, 66 (08) :694-698
[7]   Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI [J].
Huang, Wen-Hsin ;
Lee, An-Rong ;
Yang, Ching-Huey .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2006, 70 (10) :2371-2380
[8]   Possible Mechanism of the Anti-inflammatory Activity of Ruscogenin: Role of Intercellular Adhesion Molecule-1 and Nuclear Factor-κB [J].
Huang, Ya-Lin ;
Kou, Jun-Ping ;
Ma, Li ;
Song, Jia-Xi ;
Yu, Bo-Yang .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 108 (02) :198-205
[9]   Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells [J].
Kondo, S ;
Tanaka, N ;
Kubota, S ;
Mukudai, Y ;
Yosimichi, G ;
Sugahara, T ;
Takigawa, M .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (01) :129-137
[10]   Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases [J].
Kondo, S ;
Kubota, S ;
Shimo, T ;
Nishida, T ;
Yosimichi, G ;
Eguchi, T ;
Sugahara, T ;
Takigawa, M .
CARCINOGENESIS, 2002, 23 (05) :769-776